Cover Image
市場調查報告書

美國:切片檢查市場 & 數量分析

United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver & Thyroid) and Companies

出版商 Renub Research 商品編碼 349637
出版日期 內容資訊 英文 108 Pages; 28 Figures; 2 Table
商品交期: 最快1-2個工作天內
價格
Back to Top
美國:切片檢查市場 & 數量分析 United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver & Thyroid) and Companies
出版日期: 2018年02月07日 內容資訊: 英文 108 Pages; 28 Figures; 2 Table
簡介

本報告提供美國的切片檢查市場相關的總括性調查,癌症的5大市場區隔的市場分析與數量的預測,切片檢查市場促進要素與課題分析等相關彙整。

第1章 摘要整理

第2章 美國的切片檢查市場:數量、預測

  • 市場 & 預測
  • 數量 & 預測

第3章 美國的切片檢查市場 & 數量佔有率分析

  • 市場佔有率 & 預測
  • 數量佔有率 & 預測

第4章 美國的切片檢查市場 & 數量預測:檢驗市場區隔分析

  • 前列腺癌
  • 乳癌
  • 肺癌
  • 肝癌
  • 甲狀腺癌

第5章 美國的切片檢查市場:促進成長要素

第6章 美國的切片檢查市場:課題

第7章 企業分析

  • C. R. Bard, Inc.
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Olympus Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Hologic, Inc.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Renub Research report titled “United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver and Thyroid), Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, FUJIFILM Holdings Corporation, Medtronic plc., Hologic, Inc)” provides a complete analysis of the United States Biopsy Market and Volume.

Get Free Customization in This Report

United States Biopsy Market will cross US$ 17 Billion by the year 2024 owing to the rising prevalence of cancer in the region. According to the World Health Organization, cancer cases are expected to surge 57% worldwide in the next 20 years. Biopsies are most often done to look for cancer; a biopsy is a sample of tissue taken from the body in order to examine it more closely. Further, growing patient awareness and the advancement in the biopsy techniques are also expected to fuel future growth of biopsy market in United States.

The World Cancer Report, produced by the WHO's specialized cancer agency and released on World Cancer Day, predicts new cancer cases will rise from an estimated 14 million annually in 2012 to 22 million within two decades. Over the same period, cancer deaths are predicted to rise from 8.2 million a year to 13 million.

By Segment - United States Biopsy Market and Volume

On segment basis, Breast cancer biopsies accounts for the highest share in the United States Biopsy Market for the year 2017. While, in terms of Volume, Breast cancer biopsy has second highest share. Further, the report also covers the market aspects of Liver, Lung and Thyroid cancer biopsies. The Unites States Biopsy Market and Volume will experience a major growth during the forecast period owing to the increasing number of biopsy procedures and rising demand for minimally invasive procedures

All the 8 companies studied in the report have been studied from 4 points

  • Overview
  • Business Strategy
  • Merger & Acquisition
  • Financial Insight

This 108 page report with 28 Figures and 2 Tables provides a complete analysis of the key Growth Drivers and Challenges, market, and their projections for the upcoming years.

Segments Covered in the Report:

  • Breast Cancer Biopsy
  • Prostate Cancer Biopsy
  • Lung Cancer Biopsy
  • Liver Cancer Biopsy
  • Thyroid Cancer Biopsy

Key Companies Covered in the Report:

  • C. R. Bard, Inc.
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Olympus Corporation
  • FUJIFILM Holdings Corporation
  • Medtronic plc.
  • Hologic, Inc

Table of Contents

1. Executive Summary

2. United States Biopsy Market & Volume (2008-2024)

  • 2.1. Market & Forecast
  • 2.2. Volume & Forecast

3. Share Analysis-United States Biopsy (2008-2024)

  • 3.1. Market Share & Forecast
  • 3.2. Volume Share & Forecast

4. Segments Analysis-United States Biopsy Market (2008-2024)

  • 4.1. Prostate Cancer Biopsy
    • 4.1.1. Market & Forecast
    • 4.1.2. Volume & Forecast
  • 4.2. Breast Cancer Biopsy
    • 4.2.1. Market & Forecast
    • 4.2.2. Volume & Forecast
  • 4.3. Lung Cancer Biopsy
    • 4.3.1. Market & Forecast
    • 4.3.2. Volume & Forecast
  • 4.4. Liver Cancer Biopsy
    • 4.4.1. Market & Forecast
    • 4.4.2. Volume & Forecast
  • 4.5. Thyroid Cancer Biopsy
    • 4.5.1. Market & Forecast
    • 4.5.2. Volume & Forecast

5. Growth Drivers (Due to data confidentiality, growth drivers have not been disclosed in this table of contents)

  • 5.1. Point No. 1
  • 5.2. Point No. 2
  • 5.3. Point No. 3
    • 5.3.1. Point A
    • 5.3.2. Point B
    • 5.3.3. Point C
    • 5.3.4. Point D
    • 5.3.5. Point E

6. Challenges (Due to data confidentiality, challenges have not been disclosed in this table of contents)

  • 6.1. Point No. 1
  • 6.2. Point No. 2

7. Company Analysis

  • 7.1. C. R. Bard, Inc.
    • 7.1.1. Overview
    • 7.1.2. Merger & Acquisition
    • 7.1.3. Financial Insight
  • 7.2. Becton, Dickinson and Company
    • 7.2.1. Overview
    • 7.2.2. Business Strategy
    • 7.2.3. Merger & Acquisition
    • 7.2.4. Financial Insight
  • 7.3. B. Braun Melsungen AG
    • 7.3.1. Overview
    • 7.3.2. Business Strategy
    • 7.3.3. Merger & Acquisition
    • 7.3.4. Financial Insight
  • 7.4. Cardinal Health, Inc.
    • 7.4.1. Overview
    • 7.4.2. Business Strategy
    • 7.4.3. Merger & Acquisition
    • 7.4.4. Financial Insight
  • 7.5. Olympus Corporation
    • 7.5.1. Overview
    • 7.5.2. Business Strategy
    • 7.5.3. Merger & Acquisition
    • 7.5.4. Financial Insight
  • 7.6. Boston Scientific Corporation
    • 7.6.1. Overview
    • 7.6.2. Business Strategy
    • 7.6.3. Merger & Acquisition
    • 7.6.4. Financial Insight
  • 7.7. Medtronic plc
    • 7.7.1. Overview
    • 7.7.2. Business Strategy
    • 7.7.3. Merger & Acquisition
    • 7.7.4. Financial Insight
  • 7.8. Hologic, Inc.
    • 7.8.1. Overview
    • 7.8.2. Business Strategy
    • 7.8.3. Merger & Acquisition
    • 7.8.4. Financial Insight

List of Figures:

  • Figure 2 1: United States - Biopsy Market (Million US$), 2008 -2017
  • Figure 2 2: United States - Forecast for Biopsy Market (Million US$), 2018 -2024
  • Figure 2 3: United States - Biopsy Volume (Thousand), 2008 -2017
  • Figure 2 4: United States - Forecast for Biopsy Volume (Thousand), 2018 - 2024
  • Figure 3 1: United States - Biopsy Test Market Share (Percent), 2008 - 2017
  • Figure 3 2: United States - Forecast for Biopsy Test Market Share (Percent), 2018 - 2024
  • Figure 3 3: United States - Biopsy Volume Share (Percent), 2008 - 2017
  • Figure 3 4: United States - Forecast for Biopsy Volume Share (Percent), 2018 - 2024
  • Figure 4 1: United States - Prostate Cancer Biopsy Market (Million US$), 2008 -2017
  • Figure 4 2: United States - Forecast for Prostate Cancer Biopsy Market (Million US$), 2018 -2024
  • Figure 4 3: United States - Prostate Cancer Biopsy Volume (Thousand), 2008 -2017
  • Figure 4 4: United States - Forecast for Prostate Cancer Biopsy Volume (Thousand), 2018 -2024
  • Figure 4 5: United States - Breast Cancer Biopsy Market (Million US$), 2008 -2017
  • Figure 4 6: United States - Forecast for Breast Cancer Biopsy Market (Million US$), 2018 -2024
  • Figure 4 7: United States - Breast Cancer Biopsy Volume (Thousand), 2008 -2017
  • Figure 4 8: United States - Forecast for Breast Cancer Biopsy Volume (Thousand), 2018 -2024
  • Figure 4 9: United States - Lung Cancer Biopsy Market (Million US$), 2008 -2017
  • Figure 4 10: United States - Forecast for Lung Cancer Biopsy Market (Million US$), 2018 -2024
  • Figure 4 11: United States - Lung Cancer Biopsy Volume (Thousand), 2008 -2017
  • Figure 4 12: United States - Forecast for Lung Cancer Biopsy Volume (Thousand), 2018 -2024
  • Figure 4 13: United States - Liver Cancer Biopsy Market (Million US$), 2008 -2017
  • Figure 4 14: United States - Forecast for Liver Cancer Biopsy Market (Million US$), 2018 -2024
  • Figure 4 15: United States - Liver Cancer Biopsy Volume (Thousand), 2008 -2017
  • Figure 4 16: United States - Forecast for Liver Cancer Biopsy Volume (Thousand), 2018 -2024
  • Figure 4 17: United States - Thyroid Cancer Biopsy Market (Million US$), 2008 -2017
  • Figure 4 18: United States - Forecast for Thyroid Cancer Biopsy Market (Million US$), 2018 -2024
  • Figure 4 19: United States - Thyroid Cancer Biopsy Volume (Thousand), 2008 -2017
  • Figure 4 20: United States - Forecast for Thyroid Cancer Biopsy Volume (Thousand), 2018 -2024
  • Figure 7 1: C. R. Bard - Financial Insights (Million US$), 2010 - 2017
  • Figure 7 2: Becton, Dickinson and Company - Financial Insights (Million US$), 2010 - 2017
  • Figure 7 3: Becton, Dickinson and Company - Financial Insights Forecasted (Million US$), 2018 - 2024
  • Figure 7 4: B. Braun Melsungen AG - Financial Insights (Million US$), 2011 - 2017
  • Figure 7 5: B. Braun Melsungen AG - Financial Insights Forecasted (Million US$), 2018 - 2024
  • Figure 7 6: Cardinal Health, Inc. - Financial Insights (Billion US$), 2010 - 2017
  • Figure 7 7: Cardinal Health, Inc. - Financial Insights Forecasted (Billion US$), 2018 - 2024
  • Figure 7 8: Olympus Corporation - Financial Insights (Million US$), 2012 - 2017
  • Figure 7 9: Olympus Corporation - Financial Insights Forecasted (Million US$), 2018 - 2024
  • Figure 7 10: Boston Scientific Corporation - Financial Insights (Billion US$), 2012 - 2017
  • Figure 7 11: Boston Scientific Corporation - Financial Insights Forecasted (Billion US$), 2018 - 2024
  • Figure 7 12: Medtronic plc - Financial Insights (Million US$), 2010 - 2017
  • Figure 7 13: Medtronic plc - Financial Insights Forecasted (Million US$), 2018 - 2024
  • Figure 7 14: Hologic Inc. - Financial Insights (Billion US$), 2013 - 2017
  • Figure 7 15: Hologic Inc. - Financial Insights Forecast (Million US$), 2018 - 2024

List of Tables:

  • Table 6 1: New Bundled Codes for Breast Biopsy With Image Guidance
  • Table 6 2: Breast Biopsy - Final Medicare Physician Fee Schedule, 2015
Back to Top